Eagle Pharmaceuticals
EGRX
#11130
Rank
C$4.72 M
Marketcap
C$0.36
Share price
0.00%
Change (1 day)
-79.48%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): C$47.93 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are C$0.25 Billion. In 2022 the company made an earning of C$94.54 Million, an increase over its 2021 earnings that were of -C$4.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) C$47.93 M-49.3%
2022 C$94.54 M-2361.45%
2021 -C$4.19 Million-111.53%
2020 C$36.24 M2.31%
2019 C$35.42 M-32.89%
2018 C$52.78 M-50.35%
2017 C$0.10 B38.63%
2016 C$76.69 M1966.43%
2015 C$3.71 M-111.46%
2014 -C$32.4 Million282.82%
2013 -C$8.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.86 B 52,400.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.14 B 35,355.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$49.90 B 97,404.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.86 B 30,893.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.26 B 31,678.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.26 B 19,963.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.75 B 3,332.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel